IN THE UNITED STATES PATENT AND TRADEMARKOFFICE
`
`Attorney Docket No. 44854-701.402
`PATENT
`
`Inventor:
`
`BANYAI:;William
`
`Group Art Unit:
`
`1636
`
`Serial Number:
`
`15/603,013
`
`Examiner:
`
`Neil P. Hammell
`
`Filing or 371 (c) Date:
`
`2017-05-23
`
`CONFIRMATION NO:
`
`2258
`
`Title:
`
`(Track 1) DE NOVO
`SYNTHESIZED GENE
`LIBRARIES
`
`FILED ELECTRONICALLYON:January 3, 2019
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria VA 22313-1450
`
`INFORMATION DISCLOSURE STATEMENT
`UNDER37 CFR§ 1.97
`
`Commissionerfor Patents:
`
`An Information Disclosure Statement along with attached PTO/SB/08 is hereby submitted. A
`
`copy of each listed publication is submitted, if required, pursuant to 37 CFR §§$1.97-1.98, as indicated
`
`below.
`
`The Examiner is requested to review the information provided and to make the information of
`
`record in the above-identified application. The Examiner is further requested to initial and return the
`
`attached PTO/SB/08 in accordance with MPEP § 609.
`
`The right to establish the patentability of the claimed invention over any of the information
`
`provided herewith, and/or to prove that this information may not be prior art, and/or to prove that this
`
`information may not be enabling for the teachings purportedly offered, is hereby reserved.
`
`This statement is not intended to represent that a search has been made orthat the information
`
`cited in the statementis, or is considered to be, prior art or material to patentability as defined in § 1.56.
`
`Attomey Docket No. 44854-701.402
`
`

`

`A. X] 37 CFR § 1.97 (b). This Information Disclosure Statement should be considered by the Office
`because:
`
`C]
`
`(1)
`
`It is being filed within 3 monthsofthe filing date of a national application and is
`other than a continued prosecution application under § 1.53 (d);
`
`-- OR --
`
`C]
`
`(2)
`
`It is being filed within 3 months of entry of the national stage as set forth in §
`1.491 in an international application;
`
`--OR --
`
`C]
`
`(3)
`
`It is being filed before the mailing of a first Office action on the merits;
`
`--OR --
`
`XI
`
`(4)
`
`It is being filed before the mailing of a first Office action after the filing of a
`request for continued examination under § 1.114.
`B. LJ 37 CFR § 1.97(c). Although this Information Disclosure Statementis being filed after the period
`specified in 37 CFR $ 1.97(b), above, it is filed before the mailing date of the earlier of (1) a final
`office action under § 1.113, (2) a notice of allowance under § 1.311, or (3) an action that otherwise
`closes prosecution in the application, this Information Disclosure Statement should be considered
`because it is accompanied by oneof:
`LC]
`a statementas specified in §1.97 (e) provided concurrently herewith;
`
`--OR --
`
`LC]
`
`a fee of $240.00 as set forth in § 1.17 (p) authorized below, enclosed, or included with
`the paymentof other papers filed together with this statement.
`C. E] 37 CFR § 1.97 (ad). Although this Information Disclosure Statement is being filed after the
`mailing date of the earlier of (1) a final office action under § 1.113, (2) a notice of allowance under§
`1.311, or (3) an action that otherwise closes prosecution in the application, it is being filed before
`paymentof the issue fee and should be considered because it is accompanied by:
`
`1.
`
`astatement as specified in § 1.97 (e);
`
`-- AND --
`
`ii.
`
`a fee of $240.00 as set forth in §1.17(p) is authorized below, enclosed, or included
`with the payment of other papers filed together with this Statement.
`D. L] 37 CFR $1.97 (e). Statement.
`
`LC]
`
`C]
`
`C]
`
`A statement is provided herewith to satisfy the requirement under 37 CFR §§ 1.97 (c);
`
`-- AND/OR--
`
`A statement is provided herewith to satisfy the requirement under 37 CFR §§ 1.97 (d);
`
`-- AND/OR--
`
`A copy of a dated communication from a foreign patent office clearly showing that the
`information disclosure statement is being submitted within 3 monthsofthe filing date on
`the communication is provided in lieu of a statement under 37 C.F.R. § 1.97(e) (1) as
`provided for under MPEP 609.04(b) V.
`
`Attomey Docket No. 44854-701.402
`
`

`

`E. [] Statement Under 37 C.F-R. §1.704(d). Each item of information contained in the information
`disclosure statement was first cited in any communication from a patent office in a counterpart
`foreign or international application or from the Office or is a communication that was issued by a
`patent office in a counterpart foreign or international application or by the Office that was received by
`an individual designated in § 1.56(c) not more than thirty (30) days prior to the filing of this
`information disclosure statement. This statement is made pursuant to the requirements of 37 C.F.R.
`$1.704(d) to avoid reduction of the period of adjustment of the patent term for Applicant(s) delay.
`F. XX 37 CFR §1.98 (a) (2). The content of the Information Disclosure Statementis as follows:
`O
`
`Copies of each of the references listed on the attached Form PTO/SB/08 are enclosed
`herewith.
`
`-- OR --
`
`x
`
`Copies of U.S. Patent Documents (issued patents and patent publications) listed on the
`attached Form PTO/SB/08 are not enclosed.
`
`-- AND/OR--
`
`Copies of Foreign Patent Documents and/or Non Patent Literature Documents listed on
`the attached Form PTO/SB/08 are enclosed in accordance with 37 CFR $1.98 (a)(2).
`
`-- AND/OR--
`
`O
`
`Copies of pending unpublished U.S. patent applications are enclosed in accordance with
`37 CFR §1.98 (a) (2) (iii).
`G. XX 37 CFR §1.98(a)(3). The Information Disclosure Statement includes non-English patents and/or
`references.
`
`O
`
`Pursuant to 37 CFR §1.98(a)(3)(), a concise explanation of the relevance of each patent,
`publication or other information providedthatis not in English is provided herewith.
`C]
`Pursuant to MPEP 609(B), an English language copy of a foreign search report is
`submitted herewith to satisfy the requirement for a concise explanation where
`non-English language informationis cited in the search report.
`
`-- OR --
`
`C]
`
`A concise explanation of the relevance of each patent, publication or other
`information provided that is not in English is as follows:
`
`x
`
`Pursuant to 37 CFR §1.98(a) (3) Gi), a copy of a translation, or a portion thereof, of the
`non-English language reference(s) is provided herewith.
`H. L] 37 CFR §1.98(d). Copies of patents, publications and pending U.S. patent applications, or other
`information specified in 37 C.F.R. § 1.98(a) are not provided herewith because:
`O
`
`the information was previously submitted in an
`to 37 CFR $§1.98(d)(1)
`Pursuant
`Information Disclosure Statement, or cited by examiner for another application under
`which this application claims priority for an earlier effective filing date under 35 U.S.C.
`120.
`
`Application in which the information was submitted:
`
`Information Disclosure Statement(s) filed on:
`
`AND
`
`L
`
`The information disclosure statement submitted in the earlier application complied with
`paragraphs(a) through (c) of 37 CFR $1.98.
`
`Attomey Docket No. 44854-701.402
`
`3
`
`

`

`I. & Fee Authorization. The Commissioneris hereby authorized to charge the above-referenced fees
`of $0.00 and charge any additional
`fees or credit any overpayment associated with this
`communication to Deposit Account No. 23-2415 (Docket No.44854-701.402).
`
`Respectfully submitted,
`
`WILSON SONSINI GOODRICH & ROSATI
`
`By:_/David S. Harburger/
`David S. Harburger
`Registration No. 65,159
`
`Dated: January 3, 2019
`
`650 Page Mill Road
`Palo Alto, CA 94304-1050
`(650) 493-9300
`Customer No. 02-1971
`
`Attomey Docket No. 44854-701.402
`
`